BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 10885641)

  • 1. Clozapine augmentation: safety and efficacy.
    Chong SA; Remington G
    Schizophr Bull; 2000; 26(2):421-40. PubMed ID: 10885641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Treatment Strategies of Clozapine for Refractory Schizophrenia.
    Li YY; Zhang YS; Wang J; Li KQ; Wang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):666-678. PubMed ID: 28065233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations.
    Freudenreich O; Goff DC
    Acta Psychiatr Scand; 2002 Nov; 106(5):323-30. PubMed ID: 12366465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When symptoms persist: clozapine augmentation strategies.
    Buckley P; Miller A; Olsen J; Garver D; Miller DD; Csernansky J
    Schizophr Bull; 2001; 27(4):615-28. PubMed ID: 11824488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series].
    Kalenderoğlu A; Çelik M
    Turk Psikiyatri Derg; 2016; 27(1):57-62. PubMed ID: 27369686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment].
    Vayısoğlu S; Anıl Yağcıoğlu E
    Turk Psikiyatri Derg; 2014; 25(3):201-11. PubMed ID: 25219694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series.
    Se Hyun Kim ; Dong Chung Jung ; Yong Min Ahn ; Yong Sik Kim
    J Psychopharmacol; 2010 Jul; 24(7):981-6. PubMed ID: 19942641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment-refractory schizophrenia in children and adolescents: an update on clozapine and other pharmacologic interventions.
    Kranzler HN; Kester HM; Gerbino-Rosen G; Henderson IN; Youngerman J; Beauzile G; Ditkowsky K; Kumra S
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):135-59. PubMed ID: 16321728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of clozapine with another pharmacological agent: treatment for refractory schizophrenia in the 'real world'.
    Pai NB; Laidlaw M; Vella SC
    Acta Psychiatr Scand; 2012 Jul; 126(1):40-6. PubMed ID: 22432694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of combined clozapine-lithium pharmacotherapy.
    Bender S; Linka T; Wolstein J; Gehendges S; Paulus HJ; Schall U; Gastpar M
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):59-63. PubMed ID: 14731311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V; Libov I; Kotler M; Strous RD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report.
    Paraschakis A
    Clin Neuropharmacol; 2014; 37(2):60-1. PubMed ID: 24614672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
    Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
    J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The augmentation of clozapine treatment with electroconvulsive therapy.
    Gazdag G; Kocsis-Ficzere N; Tolna J
    Ideggyogy Sz; 2006 Jul; 59(7-8):261-7. PubMed ID: 17076304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine use in children and adolescents.
    Gogtay N; Rapoport J
    Expert Opin Pharmacother; 2008 Feb; 9(3):459-65. PubMed ID: 18220495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia past clozapine: what works?
    Mustafa FA
    J Clin Psychopharmacol; 2013 Feb; 33(1):63-8. PubMed ID: 23277242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.
    Wagner E; Kane JM; Correll CU; Howes O; Siskind D; Honer WG; Lee J; Falkai P; Schneider-Axmann T; Hasan A;
    Schizophr Bull; 2020 Dec; 46(6):1459-1470. PubMed ID: 32421188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.